Literature DB >> 8901668

Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM.

M W Mansfield1, D M Heywood, P J Grant.   

Abstract

BACKGROUND: First-degree relatives of patients with non-insulin-dependent diabetes mellitus (NIDDM) have an increased risk of coronary artery disease partly attributable to clustering of risk factors in association with insulin resistance. Circulating levels of some hemostatic factors predict coronary events, and there is growing evidence that insulin resistance is also associated with abnormalities of coagulation and fibrinolysis. This study examined the hypotheses that elevated levels of factor VII coagulant activity (FVII:C), fibrinogen, and von Willebrand factor (vWF) occur (1) in first-degree relatives of NIDDM patients and (2) in association with recognized features of insulin resistance. METHODS AND
RESULTS: Fasting blood samples were taken from 132 first-degree relatives of NIDDM patients and 151 age matched control subjects for measurement of FVII:C, fibrinogen, vWF, insulin, total and HDL cholesterol, triglyceride, glucose, and HbAIC. Levels of FVII:C (130% versus 122%, P < .02) and fibrinogen (3.0 versus 2.7 g/L, P = .002) were higher in relatives than in control subjects, and there was no significant difference in levels of vWF (0.98 versus 0.95 IU/mL). There was a graded association with features of insulin resistance, which was strongest for FVII:C, weaker for fibrinogen, and weakest for vWF.
CONCLUSIONS: FVII:C and fibrinogen levels are increased in relatives of patients with NIDDM. Levels of FVII:C and, to a lesser extent, fibrinogen and vWF cluster with other risk factors associated with insulin resistance. Abnormalities of circulating hemostatic factors, possibly in relation to insulin resistance, may contribute to cardiovascular risk in relatives of patients with NIDDM.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8901668     DOI: 10.1161/01.cir.94.9.2171

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  11 in total

1.  Disease risk factors identified through shared genetic architecture and electronic medical records.

Authors:  Li Li; David J Ruau; Chirag J Patel; Susan C Weber; Rong Chen; Nicholas P Tatonetti; Joel T Dudley; Atul J Butte
Journal:  Sci Transl Med       Date:  2014-04-30       Impact factor: 17.956

2.  Effects of different protein sources on plasminogen inhibitor-1 and factor VII coagulant activity added to a fat-rich meal in type 2 diabetes.

Authors:  Lene S Mortensen; Claus Thomsen; Kjeld Hermansen
Journal:  Rev Diabet Stud       Date:  2010-11-10

3.  2009 World Congress on the Insulin Resistance Syndrome: cardiovascular disease concepts.

Authors:  Zachary T Bloomgarden
Journal:  Diabetes Care       Date:  2010-07       Impact factor: 19.112

Review 4.  Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies.

Authors:  Christina Voulgari; Dimitrios Papadogiannis; Nicholas Tentolouris
Journal:  Vasc Health Risk Manag       Date:  2010-10-21

5.  Effect of the factor VII R353Q missense mutation on plasma apolipoprotein B levels: impact of visceral obesity.

Authors:  Marie-Thérèse Berthier; Alain Houde; Jean Bergeron; Denis Prud'homme; Jean-Pierre Després; Marie-Claude Vohl
Journal:  J Hum Genet       Date:  2003-07-08       Impact factor: 3.172

6.  Insulin resistance functionally limits endothelium-dependent coronary vasodilation in nondiabetic patients.

Authors:  Noriyuki Fujii; Kazufumi Tsuchihashi; Hisataka Sasao; Mariko Eguchi; Hideyuki Miurakami; Mamoru Hase; Katsuhiro Higashiura; Satoshi Yuda; Akiyoshi Hashimoto; Tetsuji Miura; Nobuyuki Ura; Kazuaki Shimamoto
Journal:  Heart Vessels       Date:  2008-02-14       Impact factor: 2.037

Review 7.  Diabetes and cardiovascular disease: pathophysiology of a life-threatening epidemic.

Authors:  R J King; P J Grant
Journal:  Herz       Date:  2016-05       Impact factor: 1.443

8.  Changes in procoagulants track longitudinally with insulin resistance: findings from the coronary artery risk development in young adults (CARDIA) study.

Authors:  O L Klein; T Okwuosa; C Chan; P Schreiner; A M Kanaya; K Liu; D Green
Journal:  Diabet Med       Date:  2014-01-17       Impact factor: 4.359

9.  Elevated properdin and enhanced complement activation in first-degree relatives of South Asian subjects with type 2 diabetes.

Authors:  Riyaz Somani; Victoria R Richardson; Kristina F Standeven; Peter J Grant; Angela M Carter
Journal:  Diabetes Care       Date:  2012-02-14       Impact factor: 19.112

Review 10.  Gut microbiota-based translational biomarkers to prevent metabolic syndrome via nutritional modulation.

Authors:  Shuiming Xiao; Liping Zhao
Journal:  FEMS Microbiol Ecol       Date:  2013-12-12       Impact factor: 4.194

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.